Cosmax Nbt（A222040）株式概要Cosmax Nbt, Inc.は、健康機能食品会社として韓国および国際的に事業を展開している。 詳細A222040 ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績0/6財務の健全性4/6配当金0/6報酬当社が推定した公正価値より33.2%で取引されている リスク分析意味のある時価総額がありません ( ₩132B )KR市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見るA222040 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₩Current Price₩6.42k67.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-24b330b2016201920222025202620282031Revenue ₩330.3bEarnings ₩34.9bAdvancedSet Fair ValueView all narrativesCosmax Nbt, Inc. 競合他社GC WellBeingSymbol: KOSDAQ:A234690Market cap: ₩151.0bCha AI HealthcareSymbol: KOSE:A025620Market cap: ₩126.6bPoledSymbol: KOSDAQ:A487580Market cap: ₩95.3bCosmax BTISymbol: KOSE:A044820Market cap: ₩172.7b価格と性能株価の高値、安値、推移の概要Cosmax Nbt過去の株価現在の株価₩6,420.0052週高値₩9,200.0052週安値₩2,860.00ベータ0.891ヶ月の変化-13.83%3ヶ月変化63.78%1年変化30.49%3年間の変化5.59%5年間の変化-41.10%IPOからの変化-55.72%最新ニュースNew Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea分析記事 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...分析記事 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).最新情報をもっと見るRecent updatesNew Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea分析記事 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...分析記事 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).分析記事 • May 07There's No Escaping Cosmax Nbt, Inc.'s (KOSDAQ:222040) Muted Revenues Despite A 25% Share Price RiseCosmax Nbt, Inc. ( KOSDAQ:222040 ) shares have continued their recent momentum with a 25% gain in the last month alone...分析記事 • Apr 24Cosmax Nbt (KOSDAQ:222040) Has No Shortage Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Mar 20Full year 2024 earnings released: ₩279 loss per share (vs ₩314 loss in FY 2023)Full year 2024 results: ₩279 loss per share (improved from ₩314 loss in FY 2023). Revenue: ₩318.0b (down 4.7% from FY 2023). Net loss: ₩5.75b (loss narrowed 11% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.お知らせ • Mar 08Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, majang-myeon, gyeonggi-do, icheon South Korea分析記事 • Feb 25Investors Don't See Light At End Of Cosmax Nbt, Inc.'s (KOSDAQ:222040) TunnelCosmax Nbt, Inc.'s ( KOSDAQ:222040 ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing...分析記事 • Oct 23Lacklustre Performance Is Driving Cosmax Nbt, Inc.'s (KOSDAQ:222040) Low P/SWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$47.7m).Buy Or Sell Opportunity • Aug 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to ₩3,040. The fair value is estimated to be ₩3,812, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has declined by 19%.分析記事 • Aug 06Cosmax Nbt (KOSDAQ:222040) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Price Target Changed • Jul 03Price target increased by 29% to ₩10,500Up from ₩8,150, the current price target is provided by 1 analyst. New target price is 166% above last closing price of ₩3,940. Stock is down 35% over the past year. The company is forecast to post earnings per share of ₩747 next year compared to a net loss per share of ₩315 last year.分析記事 • Jun 26Cosmax Nbt, Inc. (KOSDAQ:222040) Looks Inexpensive But Perhaps Not Attractive EnoughWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...分析記事 • May 21Is Cosmax Nbt, Inc. (KOSDAQ:222040) Trading At A 48% Discount?Key Insights The projected fair value for Cosmax Nbt is ₩7,493 based on 2 Stage Free Cash Flow to Equity Cosmax Nbt is...Reported Earnings • Mar 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: ₩314 loss per share (improved from ₩633 loss in FY 2022). Revenue: ₩333.6b (up 1.7% from FY 2022). Net loss: ₩6.49b (loss narrowed 50% from FY 2022). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 18% per year.分析記事 • Mar 19Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% PoundingThe Cosmax Nbt, Inc. ( KOSDAQ:222040 ) share price has fared very poorly over the last month, falling by a substantial...分析記事 • Mar 11Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Jan 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩129.7b (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Mar 26Full year 2022 earnings released: ₩633 loss per share (vs ₩309 loss in FY 2021)Full year 2022 results: ₩633 loss per share (further deteriorated from ₩309 loss in FY 2021). Revenue: ₩328.2b (up 13% from FY 2021). Net loss: ₩13.1b (loss widened 104% from FY 2021). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Nov 30Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be ₩5,427, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 43%.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Price Target Changed • May 13Price target increased to ₩14,000Up from ₩12,000, the current price target is an average from 2 analysts. New target price is 33% above last closing price of ₩10,500. Stock is up 111% over the past year.分析記事 • Apr 06Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...分析記事 • Mar 01What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?The big shareholder groups in Cosmax Nbt, Inc. ( KOSDAQ:222040 ) have power over the company. Large companies usually...Is New 90 Day High Low • Feb 26New 90-day low: ₩7,410The company is down 5.0% from its price of ₩7,800 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 13% over the same period.分析記事 • Feb 02Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five YearsSome stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...分析記事 • Jan 04Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?Cosmax Nbt, Inc. ( KOSDAQ:222040 ), is not the largest company out there, but it saw a decent share price growth in the...分析記事 • Dec 09Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Nov 18Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?If you want to know who really controls Cosmax Nbt, Inc. (KOSDAQ:222040), then you'll have to look at the makeup of...Is New 90 Day High Low • Nov 16New 90-day low: ₩7,890The company is down 13% from its price of ₩9,040 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩10,616 per share.Is New 90 Day High Low • Oct 26New 90-day low: ₩7,970The company is down 2.0% from its price of ₩8,170 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,583 per share.株主還元A222040KR Personal ProductsKR 市場7D12.2%7.7%3.4%1Y30.5%2.2%157.9%株主還元を見る業界別リターン: A222040過去 1 年間で2.2 % の収益を上げたKR Personal Products業界を上回りました。リターン対市場: A222040は、過去 1 年間で157.9 % のリターンを上げたKR市場を下回りました。価格変動Is A222040's price volatile compared to industry and market?A222040 volatilityA222040 Average Weekly Movement13.8%Personal Products Industry Average Movement8.5%Market Average Movement9.3%10% most volatile stocks in KR Market16.5%10% least volatile stocks in KR Market4.9%安定した株価: A222040の株価は、 KR市場と比較して過去 3 か月間で変動しています。時間の経過による変動: A222040の weekly volatility ( 14% ) は過去 1 年間安定していますが、依然としてKRの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2002513Jin-Hyuck Kwonwww.cosmaxnbt.com.auCosmax Nbt, Inc.は、健康機能食品会社として韓国内外で事業を展開している。また、オリジナルデザインとオリジナルブランドの製造サービスも提供している。さらに、化粧品、医薬品、医療用品も提供している。製品は錠剤、カプセル、液体、粉末サプリメントの形で提供している。同社は、B to B、流通会社、製薬会社、食品会社、ネットワーク、オンラインチャネルを通じて製品を提供している。Cosmax Nbt, Inc.は2002年に設立され、本社は韓国の城南市にある。もっと見るCosmax Nbt, Inc. 基礎のまとめCosmax Nbt の収益と売上を時価総額と比較するとどうか。A222040 基礎統計学時価総額₩131.96b収益（TTM）-₩3.65b売上高(TTM)₩308.56b0.4xP/Sレシオ-36.2xPER（株価収益率A222040 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A222040 損益計算書（TTM）収益₩308.56b売上原価₩258.96b売上総利益₩49.60bその他の費用₩53.25b収益-₩3.65b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-177.40グロス・マージン16.07%純利益率-1.18%有利子負債／自己資本比率266.6%A222040 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/01 17:49終値2026/07/01 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cosmax Nbt, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Young Ok KimDAOL Investment & Securities Co., Ltd.null nullDBS Bank LtdJi KimEugene Investment & Securities Co Ltd.5 その他のアナリストを表示
New Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).
Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea
分析記事 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...
分析記事 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).
New Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).
Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea
分析記事 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...
分析記事 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).
分析記事 • May 07There's No Escaping Cosmax Nbt, Inc.'s (KOSDAQ:222040) Muted Revenues Despite A 25% Share Price RiseCosmax Nbt, Inc. ( KOSDAQ:222040 ) shares have continued their recent momentum with a 25% gain in the last month alone...
分析記事 • Apr 24Cosmax Nbt (KOSDAQ:222040) Has No Shortage Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Mar 20Full year 2024 earnings released: ₩279 loss per share (vs ₩314 loss in FY 2023)Full year 2024 results: ₩279 loss per share (improved from ₩314 loss in FY 2023). Revenue: ₩318.0b (down 4.7% from FY 2023). Net loss: ₩5.75b (loss narrowed 11% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.
お知らせ • Mar 08Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, majang-myeon, gyeonggi-do, icheon South Korea
分析記事 • Feb 25Investors Don't See Light At End Of Cosmax Nbt, Inc.'s (KOSDAQ:222040) TunnelCosmax Nbt, Inc.'s ( KOSDAQ:222040 ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing...
分析記事 • Oct 23Lacklustre Performance Is Driving Cosmax Nbt, Inc.'s (KOSDAQ:222040) Low P/SWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$47.7m).
Buy Or Sell Opportunity • Aug 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to ₩3,040. The fair value is estimated to be ₩3,812, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has declined by 19%.
分析記事 • Aug 06Cosmax Nbt (KOSDAQ:222040) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Price Target Changed • Jul 03Price target increased by 29% to ₩10,500Up from ₩8,150, the current price target is provided by 1 analyst. New target price is 166% above last closing price of ₩3,940. Stock is down 35% over the past year. The company is forecast to post earnings per share of ₩747 next year compared to a net loss per share of ₩315 last year.
分析記事 • Jun 26Cosmax Nbt, Inc. (KOSDAQ:222040) Looks Inexpensive But Perhaps Not Attractive EnoughWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
分析記事 • May 21Is Cosmax Nbt, Inc. (KOSDAQ:222040) Trading At A 48% Discount?Key Insights The projected fair value for Cosmax Nbt is ₩7,493 based on 2 Stage Free Cash Flow to Equity Cosmax Nbt is...
Reported Earnings • Mar 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: ₩314 loss per share (improved from ₩633 loss in FY 2022). Revenue: ₩333.6b (up 1.7% from FY 2022). Net loss: ₩6.49b (loss narrowed 50% from FY 2022). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 18% per year.
分析記事 • Mar 19Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% PoundingThe Cosmax Nbt, Inc. ( KOSDAQ:222040 ) share price has fared very poorly over the last month, falling by a substantial...
分析記事 • Mar 11Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Jan 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩129.7b (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩633 loss per share (vs ₩309 loss in FY 2021)Full year 2022 results: ₩633 loss per share (further deteriorated from ₩309 loss in FY 2021). Revenue: ₩328.2b (up 13% from FY 2021). Net loss: ₩13.1b (loss widened 104% from FY 2021). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Nov 30Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be ₩5,427, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 43%.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Price Target Changed • May 13Price target increased to ₩14,000Up from ₩12,000, the current price target is an average from 2 analysts. New target price is 33% above last closing price of ₩10,500. Stock is up 111% over the past year.
分析記事 • Apr 06Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
分析記事 • Mar 01What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?The big shareholder groups in Cosmax Nbt, Inc. ( KOSDAQ:222040 ) have power over the company. Large companies usually...
Is New 90 Day High Low • Feb 26New 90-day low: ₩7,410The company is down 5.0% from its price of ₩7,800 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 13% over the same period.
分析記事 • Feb 02Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five YearsSome stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...
分析記事 • Jan 04Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?Cosmax Nbt, Inc. ( KOSDAQ:222040 ), is not the largest company out there, but it saw a decent share price growth in the...
分析記事 • Dec 09Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Nov 18Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?If you want to know who really controls Cosmax Nbt, Inc. (KOSDAQ:222040), then you'll have to look at the makeup of...
Is New 90 Day High Low • Nov 16New 90-day low: ₩7,890The company is down 13% from its price of ₩9,040 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩10,616 per share.
Is New 90 Day High Low • Oct 26New 90-day low: ₩7,970The company is down 2.0% from its price of ₩8,170 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,583 per share.
